Skip to main content

Table 3 Percentage and type of STR alterations on D19S433, D12S391, D22S1045, D2S441, D1S103, D13S790, D1S1656, SE33, PENTA E, PENTA D, Amel, D3S1768, D3S1611 and D3S2356 in the cancerous tissues

From: Forensic short tandem repeat markers alteration in cancerous tissues: a scoping review

STR Markers

Percentage of STR alteration rates (%)

BC

GCC

LC

CRC

GC

pLOH

LOH

MSI

LOH

MSI

pLOH

LOH

Aadd

Anew

pLOH

cLOH

Aadd

Anew

MSI

pLOH

cLOH

Aadd

Anew

MSI

D19S433

-

-

-

13.00–20.00

3.70

-

-

2.00

-

12.90

-

5.69

-

17.00

1.43

-

5.69

-

17.00

D12S391

-

8.33

-

-

-

4.00

5.16–67.00

-

-

-

-

-

-

-

-

-

-

-

-

D22S1045

1.43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

D2S441

1.43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

D1S103

-

18.00

4.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

D13S790

-

36.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

D1S1656

1.43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

SE33

1.43

-

-

-

7.40

-

-

-

-

-

-

-

-

-

2.86

-

-

-

-

PENTA E

-

11.11

-

-

-

-

20.83

-

-

-

17.14–26.56

-

-

-

-

19.33

-

1.22

-

PENTA D

-

-

-

-

-

-

-

2.00

-

-

-

-

-

-

-

16.80

-

-

-

Amel

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1.23

-

-

-

-

D3S1768

-

-

-

40.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

D3S1611

-

7.46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

D3S2356

-

-

-

21.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

  1. Abbr: BC Breast cancer, LC Lung cancer, CRC Colorectal cancer, GC Gastric cancer, GCC Gynecology cancer, LOH Loss of heterozygosity, cLOH Complete loss of heterozygosity, pLOH Partial loss of heterozygosity, MSI Microsatellite instability, Aadd Additional alleles, Anew New alleles,—No STR alteration